AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
The above is the analysis of the conflicting points in this earnings call
Date of Call: None provided
revenue of CNY1.24 billion in Q2 2025, up 23.9% year over year. - The growth was driven by the integration of AI with insurance and healthcare sectors, enhancing operational efficiency and productivity.CNY915 million, showing a year-on-year increase of 28.7%This expansion was attributed to increased investment in customer acquisition and technology, AI-driven enhancements in customer acquisition and conversion rates, and the introduction of new long-term medical plans.
Healthcare Sector Advancements:
34.2% year-over-year revenue growth.The growth was driven by expanded collaborations with pharmaceutical companies, increased new program initiations, and improved service capabilities through AI integration.
Operating Profit Improvement:
operating profit reached CNY340 million, indicating an 85.9% year-on-year growth.The improvement was due to increased operational efficiency, higher revenue growth than cost increases, and better management of operating expenses.
Dividend and Share Repurchase Initiatives:
$10.9 million, representing a 50% increase over the previous dividend.
Discover what executives don't want to reveal in conference calls

Dec.24 2025

Dec.24 2025

Dec.23 2025

Dec.23 2025

Dec.23 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet